Fig. 8

The 2D and 3D interaction between E. coli proteins and ligands.A, AcrB and Ciprofloxacin; (B), AcrB and Fosfomycin; (C) AcrB and enterobactin; (D), TolC and Ciprofloxacin; (E), TolC and Fosfomycin; (F), TolC and enterobactin; (G), FepA and Fe⁺³-enterobactin; (H), FepA and Fe⁺³-enterobactin-Ciprofloxacin; (I), FepA and Fe⁺³-enterobactin-Fosfomycin; (J), FepB and Fe⁺³-enterobactin; (K), FepB and Fe⁺³-enterobactin-Ciprofloxacin; (L), FepB and Fe⁺³-enterobactin-Fosfomycin; (M), FepC and Fe⁺³-enterobactin; (N), FepC and Fe⁺³-enterobactin-Ciprofloxacin; (O), FepC and Fe⁺³-enterobactin- Fosfomycin; (P), FepD and Fe⁺³-enterobactin; (Q), FepD and Fe⁺³-enterobactin-Ciprofloxacin; (R), FepD and Fe⁺³-enterobactin-Fosfomycin; (S), FepG and Fe⁺³-enterobactin; (T), FepG and Fe⁺³-enterobactin-Ciprofloxacin; (U), FepG and Fe⁺³-enterobactin-Fosfomycin; (V), DNA gyrase and Ciprofloxacin; (W), DNA gyrase and Fe⁺³-enterobactin-Ciprofloxacin; (X), MurA and Fosfomycin; (Y), MurA and Fe⁺³-enterobactin- Fosfomycin